Adaptive Platform Trials Conference

Join us for the Adaptive Platform Trials Conference in Toronto October 19 (open to all) and October 20 (by invitation only), 2026.

TreatResp is an international Adaptive Platform Trial to find effective treatments for respiratory infections. Our team includes researchers from Canada, UK, US, Australia, Chile, Sweden, Japan, and Uganda.

About the study

Our goal is to identify effective, safe, affordable, and evidence-based medications so they can be accessed by the community.

Help people with Influenza A or B feel better faster, stay out of the hospital, and evaluate comparative clinical effectiveness and cost-effectiveness, practical challenges, and outcomes.

Open to adults aged 18+ years with with at least two acute respiratory infection symptoms who tested positive within the last three to five days.

Subscribe to our newsletter

Sign up for our newsletter to keep on top of the latest TreatResp study updates and become part of our community.